SCHEMBL19620597

SCHEMBL19620597

NC1=C(OS(=O)Cc2ccccc2)C(=O)C(c2cc(F)ccc2F)O1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 6/20 0.38
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ATM Q13315 1/20 0.36
KCNH2 Q12809 2/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33
MCHR1 Q99705 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
PGR P06401 1/20 0.32
GRM5 P41594 1/20 0.32
PARK7 Q99497 2/20 0.32
MAPT P10636 2/20 0.31
NPSR1 Q6W5P4 1/20 0.31
KDM4E B2RXH2 1/20 0.30
POLB P06746 1/20 0.30
DRD2 P14416 1/20 0.30
DRD3 P35462 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22902013 0.91 CYP1A2 (0.33) DPP4MEN1KMT2AATMCYP1A2
SCHEMBL19620529 0.89 DPP4 (0.33) DPP4MEN1KMT2AATMCYP1A2
SCHEMBL19620539 0.89 CYP1A2 (0.33) CYP1A2CYP3A4CYP2C19MAPTKDM4E
SCHEMBL22902028 0.87 HTR2A (0.34) DPP4MEN1KMT2ACYP1A2CYP3A4
SCHEMBL15627599 0.84 KDM4E (0.41) MEN1KMT2AATMMAPTKDM4E
SCHEMBL22902083 0.83 KDM4E (0.39) MEN1KMT2AGRM5MAPTKDM4E
SCHEMBL19620645 0.83 KDM4E (0.36) CYP1A2CYP3A4CYP2C19GRM5MAPT
SCHEMBL19620683 0.83 HTR2C (0.32) CYP1A2CYP3A4CYP2C19GRM5MAPT
SCHEMBL19620541 0.83 KDM4E (0.37) CYP1A2CYP3A4CYP2C19MAPTKDM4E
SCHEMBL19620536 0.80 CYP1A2 (0.33) CYP1A2CYP3A4CYP2C19MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345596-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2021-01-20 EP disclosed
EP-3345596-A2 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2018-07-11 EP disclosed
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed